X.-T. Zhu, J.-Y. Liu, B. Jiang, and S.-J. Tu
Vol 000
1H, ArH), 6.13 (d, J= 6.0 Hz, 1H, NH), 5.63 (d, J= 5.6 Hz, 1H,
CH ), 3.60 (s, 6H, OCH3), 2.60 (d, J= 16.0 Hz, 1H, CH2), 2.54
(d, J= 16.0 Hz, 1H, CH2), 2.22 (d, J= 16.0 Hz, 1H, CH2), 2.08
(d, J= 16.0 Hz, 1H, CH2), 1.08 (s, 3H, CH3), 1.05 (s, 3H, CH3);
HRMS (ESI): m/z Calcd for C23H26N2NaO, 401.1835 [M + Na]+;
(m, 2H, CH2), 2.28–2.12 (m, 2H, CH2), 1.97–1.88 (m, 2H,
CH2); HRMS (ESI): m/z Calcd for C21H22N2NaO3, 373.1522
[M + Na]+; Found: 373.1531.
11-(3,4,5-Trimethoxy-phenyl)-2,3,4,5,10,11-hexahydrodibenzo
[b,e][1,4]diazepin-1-one (4q). IR (KBr, n, cmÀ1): 3543, 3263,
1
3064, 2939, 1592, 1531; H NMR (DMSO-d6) (d, ppm): 8.79 (s,
Found: 401.1852.
11-(2,3-Dimethoxy-phenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-
1H, NH), 6.91 (d, J = 8.0 Hz, 1H, ArH), 6.66–6.56 (m, 3H,
ArH), 6.40 (s, 2H, ArH), 6.17 (d, J = 6.0 Hz, 1H, NH), 5.65 (d,
J = 6.0 Hz, 1H, CH), 3.59 (s, 6H, OCH3), 3.52 (s, 3H, OCH3),
2.78–2.63 (m, 2H, CH2), 2.33–2.21 (m, 2H, CH2), 2.02–1.85
(m, 2H, CH2); HRMS (ESI): m/z Calcd for C22H24N2NaO4,
403.1628 [M+ Na]+; Found: 403.1644.
dibenzo[b,e][1,4]diazepin-1-one (4j).
IR (KBr, n, cmÀ1): 3296,
2953, 2358, 1601, 1537; 1H NMR (DMSO-d6) (d, ppm): 8.86 (s, 1H,
NH), 6.99–6.97 (m, 1H, ArH), 6.75–6.73 (m, 1H, ArH), 6.67–6.55
(m, 3H, ArH), 6.44–6.42 (m, 1H, ArH), 6.24–6.22 (m, 1H, ArH),
5.99 (d, J= 5.6 Hz, 1H, NH), 5.24 (d, J= 5.6 Hz, 1H, CH), 3.94
(s, 3H, OCH3), 3.74 (s, 3H, OCH3), 2.66 (d, J= 16.0 Hz, 1H, CH2),
2.58 (d, J= 16.0 Hz, 1H, CH2), 2.19 (d, J= 16.0 Hz, 1H, CH2), 2.03
(d, J= 16.4 Hz, 1H, CH2), 1.09 (s, 3H, CH3), 1.02(s, 3H, CH3);
HRMS (ESI): m/z Calcd for C23H26N2NaO, 401.1835 [M + Na]+;
Acknowledgments. We are grateful for the financial support from
the National Science Foundation of China (21072163, 21232004,
21272095, and 21102124), PAPD of Jiangsu Higher Education
Institutions, the NSF of Jiangsu Education Committee
(11KJB150016), Jiangsu Science and Technology Support
Program (No. BE2011045), the Qing Lan Project (12QLG006),
Doctoral Research Foundation of Xuzhou Normal University
(XZNU, No. 10XLR20), and Science and Technology
Foundation of Xuzhou (No. XJ09096).
Found: 401.1850.
11-(3,4,5-Trimethoxyphenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-
dibenzo[b,e][1,4]diazepin-1-one (4k). IR (KBr, n, cmÀ1): 3555,
1
3306, 2956, 2361, 1587; H NMR (DMSO-d6) (d, ppm): 8.78
(s, 1H, NH), 6.93 (d, 1H, J = 8.0 Hz, ArH), 6.66–6.57 (m, 3H,
ArH), 6.42(s, 2H, ArH), 6.14 (d, J = 5.6 Hz, 1H, NH), 5.64 (d,
J = 6.0 Hz, 1H, CH ), 3.59 (s, 6H, OCH3), 3.53 (s, 3H, OCH3),
2.64 (d, J = 16.0 Hz, 1H, CH2), 2.54 (d, J = 16.0 Hz, 1H, CH2),
2.25 (d, J = 16.4 Hz, 1H, CH2), 2.09 (d, J = 16.4 Hz, 1H, CH2),
1.09 (s, 3H, CH3), 1.06 (s, 3H, CH3); HRMS (ESI): m/z Calcd
REFERENCES AND NOTES
for C24H28N2NaO4, 431.1941 [M + Na]+; Found: 431.1958.
11-(2-Thienyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-dibenzo
[1] (a) Kumar, R.; Chaudhary, P.; Nimesh, S.; Verma, A. K.;
Chandra, R. Green Chem. 2006, 8, 519. (b) Fujioka, H.; Murai, K.;
Kubo, O.; Ohba, Y.; Kita, Y. Org Lett 2007, 9, 1687. (c) Hart, B.
R.; Rush, D. J.; Shea, K. J. J. Am. Chem. Soc. 2000, 122, 460. (d)
Shaabani, A.; Maleki, A.; Mofakham, H. J. Comb. Chem. 2008, 10,
595. (e) Murai, K.; Nakatani, R.; Kita, Y.; Fujioka, H. Tetrahedron,
2008, 64, 11034. (f) Ookura, R.; Kito, K.; Ooi, T.; Namikoshi, M.;
Kusumi, T. J. Org. Chem. 2008, 73, 4245. (g) Harry, M. G.; Law-
rence, L. M.; Charles, A. C.; Frederick, W. D.; Daniel, B. E.;
Hansjoerg, K.; Linda, L. S.; Manfred, W. J. Med Chem 1982, 25,
340. (h) Michelini, S.; Cassano, G. B.; Frare, F.; Perugi, G.
Pharmacopsychiatry 1996, 29, 127.
[b,e][1,4]diazepin-1-one (4m). IR (KBr, n, cmÀ1): 3308, 3240,
1
2949, 1584,1530; H NMR (DMSO-d6) (d, ppm): 8.80 (s, 1H,
NH), 7.12 (d, J = 5.2 Hz, 1H, ArH), 6.94 (d, J = 7.6 Hz, 1H,
ArH), 6.77–6.75 (m, 1H, ArH), 6.70–6.60 (m, 4H, ArH), 6.25 (d,
J = 6.0 Hz, 1H, NH), 5.91 (d, J = 5.6 Hz, 1H, CH ), 2.60 (d,
J = 16.4 Hz, 1H, CH2), 2.50 (d, J = 16.4 Hz, 1H, CH2), 2.23 (d,
J = 16.0 Hz, 1H, CH2), 2.09 (d, J = 16.0 Hz, 1H, CH2), 1.08(s,
3H, CH3), 1.05(s, 3H, CH3); HRMS (ESI): m/z Calcd for
C19H20N2NaOS, 347.1189 [M + Na]+; Found: 347.1199.
2-(1-Oxo-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-
11-yl)-benzonitrile (4n). IR (KBr, n, cmÀ1): 3387, 3294, 3078,
[2] (a) Schutz, H. Benzadiazepines, Springer, Heidelberg,
1982; vol. 2, p 240. (b) Smalley R. K., in Comprehensive Organic
Chemistry; Barton, D., Ollis, W. D., ed. Pergamon, Oxford, 1979;
vol. 4, p 600. (c) Landquist, J. K. in Comprehensive Heterocyclic
Chemistry; Katritzk, A. R., Rees, C. W., ed. Pergamon, Oxford,
1984; vol. 1, pp 166–170.
[3] (a) Fu, J.; Shuttleworth, S. J.; Connors, R. V.; Chai, A.;
Coward, P. Bioorg Med Chem Lett 2009, 19, 4264. (b) McGowan, D.;
Nyanguile, O.; Cummings, M. D.; Vendeville, S.; Vandyck, K.; Van
den Broeck, W.; Boutton, C. W.; De Bondt, H.; Quirynen, L.; Amssoms,
K; Bonfanti, J. Fr.; Last, S.; Rombauts, K.; Tahri, A.; Hu, L.; Delouvroy,
F.; Vermeiren, K.; Vandercruyssen, G.; Van der Helm, L.; Cleiren, E.;
Mostmans, W.; Lory, P.; Pille, G.; Van Emelen, K.; Fanning, G.; Pauwels,
F.; Lin, T.-I; Simmen, K.; Raboisson, P. Bioorg Med Chem Lett 2009, 19,
2492–2496.
[4] (a) Ukhin, L. Yu.; Suponitskii, K. Yu.; Shepelenko, E. N.;
Belousova, L. V.; Orlova, Zh. I.; Borodkin, G. S. Russ. Chem. Bullet.
2011, 60, 1729. (b) Cortéas, E. C.; Baños, M. A.; De Cortés, O. G.-
M. J. Heterocyclic Chem., 2004, 41, 277. (c) Cortes, E. C.; Meneses,
O. E. A.; Garcia-Mellado, O.; Zuniga, O. C.; Naranjo-Rodriguez, E.
B. J. Heterocyclic Chem. 2009, 46, 1113. (d) Tonkikh, N. N.;
Strakovs, A.; Rizhanova, K. V.; Petrova, M. V. Chem. Heterocyclic
Compounds 2004, 40, 949. (e) Cortes Cortes, E.; Hernandez Sanabria,
A. M.; Garcia-Mellado, O. J Heterocyclic Chem 2002, 39, 55. (f)
Cortes, E. C.; Cornejo, A. L. V.; de Cortes, G.-M. O. J Heterocyclic
Chem 2007, 44, 183.
1
2954, 2220, 1583; H NMR (DMSO-d6) (d, ppm): 9.10 (s, 1H,
NH), 7.70 (d, J = 7.2 Hz, 1H, ArH), 7.32–7.29 (m, 1H, ArH),
7.24–7.20 (m, 2H, ArH), 7.07 (d, J = 7.6 Hz, 1H, ArH), 6.86 (d,
J = 8.0 Hz, 1H, ArH), 6.72–6.68(m, 1H, ArH), 6.65–6.61 (m,
1H, ArH), 6.52 (d, J = 7.6 Hz, 1H, ArH), 5.95 (d, J = 6.0 Hz, 1H,
NH), 5.85 (d, J = 6.0 Hz, 1H, CH), 2.81–2.68 (m, 2H, CH2),
2.29–2.10 (m, 2H, CH2), 1.96–1.89 (m, 2H, CH2); HRMS (ESI):
m/z Calcd for C20H17N3NaO, 338.1263 [M + Na]+; Found:
338.1274.
11-p-Tolyl-2,3,4,5,10,11-hexahydrodibenzo[b,e][1,4] diazepin-
1-one (4o).
IR (KBr, n, cmÀ1): 3304, 3067, 2945, 2361,
1
1599; H NMR (DMSO-d6) (d, ppm): 8.74(s, 1H, NH), 6.98–
6.96 (m, 2H, ArH), 6.90–6.87(m, 3H, ArH), 6.61–6.52 (m, 3H,
ArH),6.19(d, J = 6.4 Hz, 1H, NH), 5.67 (d, J = 6.0 Hz, 1H, CH),
2.75–2.62 (m, 2H, CH2), 2.29–2.19 (m, 2H, CH2), 2.13 (s, 3H,
CH3) , 1.99–1.88 (m, 2H, CH2); HRMS (ESI): m/z Calcd for
C20H20N2NaO, 327.1467 [M + Na]+; Found: 327.1484.
11-(2,3-Dimethoxy-phenyl)-2,3,4,5,10,11-hexahydrodibenzo
[b,e][1,4]diazepin-1-one (4p). IR (KBr, n, cmÀ1): 3349, 3299,
3240, 3149, 1600, 1535; 1H NMR (DMSO-d6) (d, ppm): 8.88 (s,
1H, NH), 6.97–6.95 (m, 1H, ArH), 6.75–6.72 (m, 1H, ArH),
6.66–6.54 (m, 3H, ArH), 6.43–6.41 (m, 1H, ArH), 6.24–6.22
(m, 1H, ArH), 5.97 (d, J = 5.6 Hz, 1H, NH), 5.22 ( d, J = 6 Hz,
1H, CH ), 3.93 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 2.80–2.66
[5] Kolos, N. N.; Yurchenko, E. N.; Orlov, V. D.; Shishkina, S.
V.; Shishkin, O. V. Chem Heterocyclic Compd 2004, 40, 1550.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet